A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN

BACKGROUND: While pain freedom at 2 h is a key primary outcome for current trials for acute treatment of migraine, the relationship between the degree of head pain and other efficacy measures at 2 h has rarely been explored. Following lasmiditan treatment of a migraine attack with moderate or severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipton, Richard B., Baygani, Simin K., Tepper, Stewart J., Krege, John H., Vasudeva, Raghavendra, Pearlman, Eric M., Hauck, Paula M., Loo, Li Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400846/
https://www.ncbi.nlm.nih.gov/pubmed/34454420
http://dx.doi.org/10.1186/s10194-021-01303-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400846/
https://www.ncbi.nlm.nih.gov/pubmed/34454420
http://dx.doi.org/10.1186/s10194-021-01303-w

Ejemplares similares